 |
 |

Prepublication Release of Medical Research
Phil B. Fontanarosa, MD;
Annette Flanagin, RN, MA
JAMA. 2000;284:2927-2929.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Exactly when and how findings from medical research studies should be disseminated to clinicians, other researchers, and the public is a critically important yet contentious issue.1-4 The tradeoffs between expediency and ensuring quality and accuracy have long been recognized and debated but have come under increasing attention recently, particularly with the use of electronic media for communication of medical research findings. Medical researchers, especially those involved in major studies, usually want to communicate the results of their research as widely and as quickly as possible. Journalists, well aware of the public's "right to know" and seemingly insatiable desire for information about health and medicine, are interested in promptly reporting medical news, especially about potential "breakthrough" research findings. However, journal editors, responsible for ensuring that the scientific information they publish is assessed for quality by peer review and editorial evaluation, generally discourage prepublication . . . [Full Text of this Article]
Author Affiliations: Dr Fontanarosa is Executive Deputy Editor and Ms Flanagin is Managing Senior Editor, JAMA.
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
RELATED ARTICLES
Relation Between Prepublication Release of Clinical Trial Results and the Practice of Carotid Endarterectomy
Cary P. Gross, Claudia A. Steiner, Eric B. Bass, and Neil R. Powe
JAMA. 2000;284(22):2886-2893.
ABSTRACT
| FULL TEXT
THE JOURNAL's Policy Regarding Release of Information to the Public
Phil B. Fontanarosa, Annette Flanagin, and Catherine D. DeAngelis
JAMA. 2000;284(22):2929-2931.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Transition From Meeting Abstract to Full-length Journal Article for Randomized Controlled Trials
Toma et al.
JAMA 2006;295:1281-1287.
ABSTRACT
| FULL TEXT
Impact of the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22/Reversal of Atherosclerosis With Aggressive Lipid Lowering Trials on Trends in Intensive Versus Moderate Statin Therapy in Ontario, Canada
Austin and Mamdani
Circulation 2005;112:1296-1300.
ABSTRACT
| FULL TEXT
Media Coverage of Scientific Meetings: Too Much, Too Soon?
Schwartz et al.
JAMA 2002;287:2859-2863.
ABSTRACT
| FULL TEXT
When Should the Public Be Informed of the Results of Medical Research?
Holtz et al.
JAMA 2001;286:2944-2945.
FULL TEXT
Prepublication Release of Clinical Trial Results
Journal Watch Cardiology 2001;2001:13-13.
FULL TEXT
Prepublication Release of Clinical Trial Results
JWatch General 2001;2001:6-6.
FULL TEXT
|